Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Solara Active Pharma Sciences Ltd

SOLARA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$5.37

▼ -1.17%

Market Cap $258.00M · Vol 76.95K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$258.00M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

54.91

Momentum

Beta

1.80

vs Market

52W High

$7.46

33.30% below

52W Low

$4.42

20.02% above

Volume

76.95K

Avg 257.81K

P/B

1.63

Price-to-book

ROE

N/A

Return on equity

Free Float

46.78%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Solara Active Pharma Sciences Ltd (SOLARA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SOLARA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.93%

-11.09%

+0.91%

+2.54%

YTD

-9.32%

-14.20%

+31.17%

-67.68%

Financials & Valuation

TTM · Annual

Total Revenue	$146.48M
Net Income	$-792,878.00
Revenue Growth (YoY)	+19.57%
Gross Margin	42.72%
Operating Margin	6.36%
Net Profit Margin	-0.54%
ROE	N/A
ROA · ROIC	-0.32% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.37
P/B	1.63
P/FCF	211.37
EPS Growth	N/A
Outstanding Shares	48.25M

Technical Indicators

50-Day SMA	$5.77
200-Day SMA	$5.55
RSI (14)	54.91
Beta	1.80
52-Week High	$7.46
52-Week Low	$4.42

Volume Today	76.95K
Avg Daily Volume (30D)	257.81K
Relative Volume	0.30x
Volatility (10D)	22.36
Volatility (30D)	30.54
Free Float	46.78%

Analyst Consensus

N/A

Current Price $5.37

Mean Target N/A

52W Low$4.42 52W High$7.46

Current

Target

$4.42 $7.46

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG00G9GRND5

ISININE624Z01016

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.